Replies to post #30712 on Ayala Pharmaceuticals Inc (ADXS)

[sandman44]

Great plan FBG I second the motion , PUT THE FOR SALE SIGN UP ASAP , ADXS !!!!

[Traderbx]

Just EU approval next year will make ADXS break $20s... why do we want to undersell a $100+ potential buyout?

[blueyedcatch]

Adxs board of directors,,please pay no heed to anyone asking to you to sell the company for chump change when we`re so close to an EU and FDA approval. Obviously these requests come from impatient investors who want to be payed here, and be done. Patience is severely lacking in these investors, and their wishes are detrimental to the future potential of Adxs. If Adxs the company was like a new and beautiful home being built,,these investors would want to sell it before it`s 80% completed. Obviously if you did that you would`nt get anything close to what you`d get if you completed the house first,before you sold it..GlTY anyway,but if you want the company sold for 20.00 a share,then you`re on your own for sure,because no one invested for so many years would short change themselves so severely and so prematurely,when it looks like victory is close at hand. How does anyone trust someone who would do that,or ask for that? Since I asked for Dan to be let go,,I`m gonna call the board and make sure they pay you no heed what so ever. Seriously,,I will. Adage won`t accept 20.00,especially when they bought for 19 a share. A 20.00-25.00 a share buyout is nothing but Fud babble.

[exel_mm]

<Filter>OFF</Filter>
Yes, do what's right for investors and sell the platform for $0.
Do the math.
<Filter>ON</Filter>

[Chemist823]

"ADXS Board of Directors, please consider putting the company on the auction block and selling for $20 to $25 ($800 million to $1 billion valuation). Arguably, this would be in the best interest of 1) patients (getting the constructs to market faster with trial execution done by the expertise of a larger pharma or biotech) and 2) ADXS investors (who are down 50% from the recapitalization price of $12 over the last four years). Why risk putting into place another CEO who turns out to fumble in advancing the platform (Moore) or one who turns out to be unethical and puts his personal financial interests above shareholder interests (O'Connor). In the latest corporate presentation, you cite around $1 billion of potential future deal value based on current collaborations - you should be able to sell the entire company for approximately this value ($20 to $25 share price). Do what's right for the company, its patients and investors. "

Stock price over $6 Aug 22, 2017, now $3.

I'm not really in the sell the company now camp but would be ok with a sale. I would rather they sale an asset or make a couple deals and get the EMA sub done. Last I heard the EMA doesn't approve drugs that aren't submitted.